Pharming Group N.V.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $244.1M | $462.9M | $61.7M |
| FY2024 | $178.9M | $400.0M | $54.9M |
| FY2025 | $222.9M | $500.0M | $145.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $244.1M | $462.9M | $61.7M |
| FY2024 | $178.9M | $400.0M | $54.9M |
| FY2025 | $222.9M | $500.0M | $145.3M |